In Q2, maize revenue growth declined due to majority sales in Q1. Consolidated numbers include contributions from subsidiaries like Microtech Genomics. Future buybacks depend on shareholder benefits. Company focuses on export growth in markets like Vietnam and Ivory Coast for a 15% annual increase.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing